Abstract
The recently developed proteomic technology features high-throughput parallel analysis of all proteins expressed from a genome, and thus opens up the possibility of providing details on the molecular mechanisms in a global level. Proteomic approaches combined with other biochemical methods can reconstruct regulatory networks, signaling cascades and metabolic pathways upon drug treatment. In this review, an overview will be given on recent progresses in proteomic research strategies that have an impact on drug discovery and their applications in illustrating action mechanisms of anticancer drugs including angiogenesis inhibitors, predicting drug resistance, and examining signaling pathways and phosphoproteome alterations upon drug treatment. The review concludes by exemplifying concrete datadriven studies in pharmaceutical research, which demonstrate the value of integrated proteomic platforms for drug target identification and validation, screening assay development, as well as the evaluations of drug candidate efficacy and toxicity.
Keywords: Proteomics, drug mechanism, drug target
Current Drug Discovery Technologies
Title: Proteomics Approach to Illustrate Drug Action Mechanisms
Volume: 3 Issue: 3
Author(s): Ying Wang, Jen-Fu Chiu and Qing-Yu He
Affiliation:
Keywords: Proteomics, drug mechanism, drug target
Abstract: The recently developed proteomic technology features high-throughput parallel analysis of all proteins expressed from a genome, and thus opens up the possibility of providing details on the molecular mechanisms in a global level. Proteomic approaches combined with other biochemical methods can reconstruct regulatory networks, signaling cascades and metabolic pathways upon drug treatment. In this review, an overview will be given on recent progresses in proteomic research strategies that have an impact on drug discovery and their applications in illustrating action mechanisms of anticancer drugs including angiogenesis inhibitors, predicting drug resistance, and examining signaling pathways and phosphoproteome alterations upon drug treatment. The review concludes by exemplifying concrete datadriven studies in pharmaceutical research, which demonstrate the value of integrated proteomic platforms for drug target identification and validation, screening assay development, as well as the evaluations of drug candidate efficacy and toxicity.
Export Options
About this article
Cite this article as:
Wang Ying, Chiu Jen-Fu and He Qing-Yu, Proteomics Approach to Illustrate Drug Action Mechanisms, Current Drug Discovery Technologies 2006; 3 (3) . https://dx.doi.org/10.2174/157016306780136763
DOI https://dx.doi.org/10.2174/157016306780136763 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers
Current Drug Metabolism The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry Anionic Antimicrobial Peptides from Eukaryotic Organisms
Current Protein & Peptide Science First Ayurvedic Approach Towards Green Drugs: Anti Cervical Cancer-Cell Properties of Clerodendrum viscosum Root Extract
Anti-Cancer Agents in Medicinal Chemistry Folate Deficiency and Aberrant Expression of DNA Methyltransferase 1 were Associated with Cervical Cancerization
Current Pharmaceutical Design The Use of Oncolytic Vaccinia Viruses in the Treatment of Cancer: A New Role for an Old Ally?
Current Gene Therapy Seocalcitol (EB 1089) A Vitamin D Analogue of Anti-cancer Potential. Background, Design, Synthesis, Pre-clinical and Clinical Evaluation
Current Pharmaceutical Design Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy The Impact of HAART on HPV-Related Cervical Disease
Current HIV Research Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula
Current Bioinformatics Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives
Anti-Cancer Agents in Medicinal Chemistry Molecular Pathways Linking Inflammation and Cancer
Current Molecular Medicine Use of Liposomal Drugs in the Treatment of Rheumatoid Arthritis
Current Rheumatology Reviews Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Recent Patents on Anti-Cancer Drug Discovery Analysis of miRNAs Targeting 3’UTR of H2AFX Gene: a General <i>in Silico</i> Approach
MicroRNA PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update
Current Pharmaceutical Design Antiviral Effects of Saffron and its Major Ingredients
Current Drug Delivery CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease
Current Alzheimer Research VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis
Current Medicinal Chemistry Applications of Nuclear Technique to Biological Sciences Labelled Compounds, Radioactive Tracers, and X-Ray Tomography
Current Topics in Medicinal Chemistry